Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
ILMN [NASD]
Illumina Inc.
Index- P/E70.69 EPS (ttm)2.90 Insider Own1.10% Shs Outstand144.10M Perf Week2.98%
Market Cap29.54B Forward P/E50.05 EPS next Y4.10 Insider Trans-27.59% Shs Float142.61M Perf Month6.44%
Income430.00M PEG3.36 EPS next Q0.77 Inst Own95.20% Short Float2.27% Perf Quarter2.02%
Sales1.98B P/S14.93 EPS this Y163.30% Inst Trans0.08% Short Ratio2.84 Perf Half Y7.88%
Book/sh11.29 P/B18.16 EPS next Y19.52% ROA13.10% Target Price229.88 Perf Year30.26%
Cash/sh9.48 P/C21.62 EPS next 5Y21.03% ROE31.60% 52W Range145.12 - 213.33 Perf YTD11.06%
Dividend- P/FCF79.45 EPS past 5Y34.90% ROI15.20% 52W High-3.90% Beta0.90
Dividend %- Quick Ratio2.60 Sales past 5Y22.80% Gross Margin70.50% 52W Low41.26% ATR4.25
Employees3700 Current Ratio2.90 Sales Q/Q28.00% Oper. Margin26.30% RSI (14)70.35 Volatility1.32% 2.25%
OptionableYes Debt/Eq0.80 EPS Q/Q130.00% Profit Margin21.70% Rel Volume0.95 Prev Close203.12
ShortableYes LT Debt/Eq0.61 EarningsApr 21 AMC Payout0.00% Avg Volume1.14M Price205.00
Recom1.90 SMA205.94% SMA507.23% SMA20010.82% Volume1,088,360 Change0.93%
May-21-15Upgrade Morgan Stanley Equal-Weight → Overweight $162 → $190
Apr-22-15Reiterated Mizuho Buy $220 → $230
Mar-10-15Initiated UBS Buy $240
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
May-21-15 10:09AM  Illumina upgraded by Morgan Stanley
08:53AM  Weakness Seen in Achillion Pharmaceuticals (ACHN): Stock Tumbles 15.3% - Tale of the Tape
06:30AM  Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June Business Wire
May-20-15 09:50AM  Actavis Plc (ACT), Illumina Inc (LMN) and Cheniere Energy Inc (LNG) Among Billionaire Halvorsens Top Stock picks at Insider Monkey
May-19-15 09:39AM  Billionaire Stanley Druckenmillers Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc (BIIB), LyondellBasell Industries NV (LYB) at Insider Monkey
08:35AM  Oncothyreon (ONTY) Looks Good: Stock Up 6.6% in Session - Tale of the Tape
May-18-15 06:15PM  Large-Cap Growth Stocks: New Safe Haven For Investors? at Investor's Business Daily
04:05PM  Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. and Roche Molecular Systems, Inc. Business Wire
May-15-15 03:35PM  Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog
11:26AM  Prestige Brands Holdings Beats on Q4 Earnings, Revenues - Analyst Blog
May-13-15 09:40AM  3 Biotech Stocks See Growing Short Interest
May-12-15 04:26PM  BioDelivery (BDSI) Q1 Loss Narrower-Than-Expected - Analyst Blog
09:30AM  Illumina, US Silica Holdings, Shake Shack, Red Robin Gourmet Burgers and Chuy's Holdings highlighted as Zacks Bull and Bear of the Day - Press Releases
08:11AM  Bull of the Day: Illumina (ILMN) - Bull of the Day
May-04-15 12:40PM  Integra LifeSciences Tops Q1 Earnings, Revenues; View Up - Analyst Blog
08:50AM  Can Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape
May-03-15 08:13PM  10-Q for Illumina, Inc. at Company Spotlight
May-01-15 06:00PM  Cramer's move next week
05:24PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report
11:55AM  Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog
Apr-29-15 07:00AM  DNA Sequencing Market Will Exceed $20 Billion, Says Illumina CEO Jay Flatley at Forbes
06:51AM  Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference at noodls
06:30AM  Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference Business Wire
Apr-23-15 10:30AM  3 Top Stocks to Buy That Delivered Great Earnings at 24/7 Wall St.
06:00AM  Intel-Edico partnership aims to break a medical logjam at Fortune
Apr-22-15 06:39PM  Cloud Health Launches Full Service Capacity of the Illumina HiSeq X Ten Sequencing System at noodls
01:35PM  Stocks Higher After Soft Start; Facebook Up Pre-Earnings at Investor's Business Daily
11:53AM  Stocks Mildly Higher; China Nods To Visa, MasterCard at Investor's Business Daily
10:38AM  Stocks Take A Quiet Step Back; McDonald's, Visa, Tesla Climb at Investor's Business Daily
10:15AM  Illumina (ILMN) Tops Q1 Earnings, Revenues; EPS View Up - Analyst Blog
07:58AM  Illumina (ILMN) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-21-15 06:44PM  Yum! Brands, Chipotle, United Rentals Lead Tuesday's After-Hours Movers
06:00PM  Amgen, Illumina Earnings Hot, Intuitive Surgical Not at Investor's Business Daily
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today
04:27PM  Illumina beats Street 1Q forecasts
04:19PM  Illumina Reports Strong Start to Fiscal Year 2015 at noodls
04:08PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Reports Strong Start to Fiscal Year 2015 Business Wire
02:40PM  Will Thermo Fisher's (TMO) Q1 Earnings Surprise Investors? - Analyst Blog
09:56AM  Stocks narrowly mixed amid earnings; Nasdaq leads gains at CNBC
08:08AM  Wall Street optimistic on bumper earnings day at CNBC
07:28AM  Startup Pledges To Cut Cost Of Breast Cancer Genetic Testing From $4000 To $249 at Forbes
07:07AM  Q1 2015 Illumina Inc Earnings Release - After Market Close
Apr-20-15 03:15PM  Billionaire Andreas Halvorsens New Healthcare Pick at Insider Monkey
09:01AM  Immune System Drugs Melt Tumors In New Study, Leading A Cancer Revolution at Forbes
Apr-17-15 01:40PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog
Apr-15-15 08:54AM  Why Illumina (ILMN) Might Surprise This Earnings Season - Tale of the Tape
Apr-14-15 05:30PM  Douglas C. Lane's Top Three Stocks for Q1 2015: Delta, United Continental and Illumina
Apr-08-15 12:02PM  It Takes Two To Tango: Combine Diagnostics And Drugs For Precision Medicine at Forbes
Apr-07-15 06:32AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 at noodls
06:30AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 Business Wire
Apr-01-15 08:14PM  Fetal DNA tests prove highly accurate but experts warn of exceptions Reuters
Mar-31-15 09:24AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance at noodls
09:19AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance Business Wire
Mar-27-15 09:30AM  The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics - Press Releases
09:30AM  The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases
Mar-26-15 03:35PM  3 Biotech Stocks Bucking Short Interest Trends
02:55PM  The March Madness 'Sweet 16' of Stocks - Analyst Blog
02:12PM  Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks at Forbes
10:21AM  Biotech Crash -- How Long Will It Last? at Forbes
Mar-25-15 07:22PM  3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News
Mar-23-15 05:45PM  Health Care REIT Stocks Find Investors' Favor at Investor's Business Daily
10:03AM  Illumina Launches the NeoPrep Library Prep System at noodls
09:35AM  Illumina Names Albiogen as Eastern Europe Distributor at noodls
09:35AM  Illumina Launches TruSight HLA Solution at noodls
09:35AM  Illumina Files Patent Infringement Suit in the United Kingdom Against Premaitha Health plc for Infringement of NIPT Patents at noodls
09:35AM  Illumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology at noodls
09:35AM  Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates at noodls
09:30AM  The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest Diagnostics and Illumina - Press Releases
Mar-20-15 06:05PM  Illumina (ILMN) Files NIPT Patent Infringement Suit in UK - Analyst Blog
03:18PM  International Day of Happiness: Stocks to Make You Smile - Analyst Blog
Mar-18-15 09:03AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer at noodls
08:31AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer PR Newswire
Mar-17-15 08:03AM  Billionaire Stan Druckenmillers Long-Term Picks at Insider Monkey
Mar-16-15 10:22AM  Analyzing Viking Global Investors Positions in 4Q14
04:05AM  Illumina Files Patent Infringement Suit in the United Kingdom Against Premaitha Health plc for Infringement of NIPT Patents Business Wire
Mar-13-15 04:00PM  Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog
Mar-12-15 06:11PM  Illumina Partners Merck KGaA to Develop Precision Medicine - Analyst Blog
Mar-10-15 09:00AM  Illumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology Business Wire
Mar-04-15 06:30AM  Illumina Launches TruSight HLA Solution Business Wire
Mar-03-15 05:04PM  Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog
05:45AM  Illumina attracts vote of confidence
Feb-26-15 06:30AM  Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates Business Wire
Feb-25-15 08:00AM  10X Genomics Unwraps Its 'Toaster Oven' For Better DNA Sequencing at Forbes
Feb-24-15 11:19PM  Thermo Fisher Scientific, Ingersoll-Rand plc: Billionaires Are Piling Into These 5 Capital Goods Stocks at Insider Monkey
06:51PM  Illumina Expands NGS Portfolio with NeoPrep Library System - Analyst Blog
01:04PM  ILLUMINA INC Financials
08:00AM  Five Things To Watch For At The Big Genomics Event at Forbes
Feb-23-15 06:30AM  Illumina Launches the NeoPrep Library Prep System Business Wire
Feb-20-15 07:07PM  10-K for Illumina, Inc. Company Spotlight
01:10PM  What 23andMe's FDA Approval Means For The Future Of Genomics at Forbes
01:03AM  Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc: Billionaire Halvorsens Top 3 Picks at Insider Monkey
Feb-19-15 10:15PM  In Big Shift, FDA Plans To Let 23andMe Market Genetic Tests To Consumers at Forbes
Feb-18-15 06:30AM  Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire
06:05AM  ILLUMINA INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-16-15 07:15PM  Billionaire Stanley Druckenmillers Top 5 Picks Include Biogen Idec Inc (BIIB), Target Corporation (TGT), Home Depot Inc (HD) at Insider Monkey
Feb-13-15 05:08PM  Sony Betting Streaming Video Puts Its Comeback Into Focus at Investor's Business Daily
Feb-05-15 12:10PM  TrialReach Raises $13.5M Series B Led by Smedvig Capital PR Newswire
Feb-03-15 09:37AM  Illumina (ILMN) Stock Declines Today Despite Price Target Increase at TheStreet
08:35AM  Obama's New Healthcare Proposal: A Precise Vision Or A Political Football at Forbes
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALT DAVID RDirectorMay 19Sale202.0010,0002,020,042762,427May 19 06:07 PM
Naclerio NicholasSr VP, Corporate DevelopmentMay 15Sale199.166,5901,312,48734,867May 19 05:31 PM
FLATLEY JAY TChief Executive OfficerMay 14Option Exercise33.8025,000844,875449,996May 15 09:06 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 14Sale198.523,751744,64035,557May 15 08:55 PM
FLATLEY JAY TChief Executive OfficerMay 14Sale197.7625,0004,944,122424,996May 15 09:06 PM
Bianchi Paul LSr. VP, Human ResourcesMay 13Sale197.143,356661,60264,531May 14 07:14 PM
Stapley MarcSr VP & CFOMay 12Option Exercise36.302,40087,12021,498May 14 08:10 PM
WALT DAVID RDirectorMay 12Sale196.292,000392,58058,960May 14 07:07 PM
WALT DAVID RDirectorMay 12Sale196.205,000981,020772,427May 14 07:07 PM
Bouchard MichelChief Accounting OfficerMay 12Sale195.721,400274,00819,208May 14 07:28 PM
Stapley MarcSr VP & CFOMay 12Sale196.163,000588,46618,498May 14 08:10 PM
EPSTEIN ROBERT SDirectorMay 11Option Exercise51.172,000102,3409,042May 12 09:28 PM
EPSTEIN ROBERT SDirectorMay 11Sale196.492,000392,9807,042May 12 09:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 05Option Exercise69.3411,500797,41050,808May 07 06:29 PM
WHITFIELD ROY ADirectorMay 05Option Exercise39.144,500176,13016,238May 07 06:58 PM
WALT DAVID RDirectorMay 05Sale186.275,000931,344777,427May 07 06:14 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 05Sale186.6011,5002,145,91439,308May 07 06:29 PM
WHITFIELD ROY ADirectorMay 05Sale188.424,500847,89011,738May 07 06:58 PM
Dadswell CharlesSr VP & General CounselApr 30Sale185.8812923,97941,822May 01 07:57 PM
WALT DAVID RDirectorApr 28Sale183.922,000367,83460,960Apr 30 07:00 PM
WALT DAVID RDirectorApr 28Sale183.865,000919,294782,427Apr 30 07:00 PM
Dadswell CharlesSr VP & General CounselApr 27Sale190.04346,46141,951Apr 28 07:25 PM
BOWMAN A BLAINEDirectorApr 24Option Exercise39.143,000117,42015,722Apr 28 07:14 PM
BOWMAN A BLAINEDirectorApr 24Sale190.733,000572,19912,722Apr 28 07:14 PM
FLATLEY JAY TChief Executive OfficerApr 23Option Exercise33.8025,000844,875449,996Apr 27 05:54 PM
FLATLEY JAY TChief Executive OfficerApr 23Sale189.5725,0004,739,274424,996Apr 27 05:54 PM
WALT DAVID RDirectorApr 21Sale197.9510,0001,979,515787,427Apr 23 07:21 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficApr 15Sale189.023,751709,02139,308Apr 16 06:38 PM
Naclerio NicholasSr VP, Corporate DevelopmentApr 15Sale189.056,5901,245,81041,457Apr 16 06:33 PM
WALT DAVID RDirectorApr 14Sale188.172,000376,33662,960Apr 15 06:59 PM
WALT DAVID RDirectorApr 14Sale188.255,000941,247797,427Apr 15 06:59 PM
Stapley MarcSr VP & CFOApr 13Option Exercise36.302,40087,12022,098Apr 15 06:26 PM
Bianchi Paul LSr. VP, Human ResourcesApr 13Sale187.223,390634,67667,887Apr 15 06:00 PM
Stapley MarcSr VP & CFOApr 13Sale190.123,000570,37319,098Apr 15 06:26 PM
Bouchard MichelChief Accounting OfficerApr 13Sale188.611,400264,05420,608Apr 15 07:11 PM
FLATLEY JAY TChief Executive OfficerApr 09Option Exercise33.8025,000844,875449,996Apr 13 07:02 PM
FLATLEY JAY TChief Executive OfficerApr 09Sale184.5525,0004,613,815424,996Apr 13 07:02 PM
BRADBURY DANIELDirectorApr 08Option Exercise75.661,700128,62214,166Apr 10 06:55 PM
BRADBURY DANIELDirectorApr 08Sale185.321,700315,04212,466Apr 10 06:55 PM
WALT DAVID RDirectorApr 07Sale184.285,000921,404802,427Apr 08 09:16 PM
WHITFIELD ROY ADirectorApr 06Option Exercise19.614,60090,20616,338Apr 08 07:40 PM
WHITFIELD ROY ADirectorApr 06Sale181.324,600834,07211,738Apr 08 07:40 PM
WALT DAVID RDirectorMar 31Sale186.005,000930,001807,427Apr 02 07:15 PM
WALT DAVID RDirectorMar 31Sale185.982,000371,95264,960Apr 02 07:15 PM
Dadswell CharlesSr VP & General CounselMar 27Sale184.629918,27742,690Mar 31 05:51 PM
FLATLEY JAY TChief Executive OfficerMar 26Option Exercise33.8025,000844,875449,996Mar 30 08:23 PM
FLATLEY JAY TChief Executive OfficerMar 26Sale181.3425,0004,533,467424,996Mar 30 08:23 PM
WALT DAVID RDirectorMar 24Sale192.165,000960,791812,427Mar 26 08:19 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise39.143,000117,42015,722Mar 19 08:58 PM
BOWMAN A BLAINEDirectorMar 17Sale192.303,000576,90812,722Mar 19 08:58 PM
WALT DAVID RDirectorMar 17Sale192.575,000962,836817,427Mar 19 07:52 PM
WALT DAVID RDirectorMar 17Sale192.602,000385,19666,960Mar 19 07:52 PM
MOELLER GERALDDirectorMar 16Option Exercise75.662,700204,28220,244Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Option Exercise75.661,700128,62214,166Mar 18 08:47 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMar 16Sale191.595,001958,16243,059Mar 18 08:47 PM
MOELLER GERALDDirectorMar 16Sale193.362,700522,07317,544Mar 18 08:46 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 16Sale193.946,5901,278,05748,047Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Sale194.111,700329,99412,466Mar 18 08:47 PM
Bianchi Paul LSr. VP, Human ResourcesMar 13Sale186.673,390632,81171,277Mar 16 06:21 PM
Stapley MarcSr VP & CFOMar 12Option Exercise36.302,40087,12023,012Mar 13 07:36 PM
FLATLEY JAY TChief Executive OfficerMar 12Option Exercise33.8025,000844,875452,850Mar 16 06:46 PM
Bouchard MichelChief Accounting OfficerMar 12Sale189.951,752332,79222,008Mar 31 09:40 PM
Stapley MarcSr VP & CFOMar 12Sale189.013,314626,38819,698Mar 13 07:36 PM
FLATLEY JAY TChief Executive OfficerMar 12Sale189.4525,0004,736,126427,850Mar 16 06:46 PM
EPSTEIN ROBERT SDirectorMar 10Option Exercise51.172,000102,34010,042Mar 11 07:46 PM
EPSTEIN ROBERT SDirectorMar 10Sale191.753,000575,2507,042Mar 11 07:46 PM
Klausner RichardSr VP, Chief Medical OfficerMar 10Sale191.751,186227,41624,948Mar 11 07:46 PM
WALT DAVID RDirectorMar 10Sale192.385,000961,908822,427Mar 12 05:55 PM
WHITFIELD ROY ADirectorMar 05Option Exercise19.614,60090,20616,338Mar 09 08:32 PM
WHITFIELD ROY ADirectorMar 05Sale194.684,600895,50811,738Mar 09 08:32 PM
WALT DAVID RDirectorMar 03Sale193.675,000968,361827,427Mar 05 08:30 PM
WALT DAVID RDirectorMar 03Sale193.752,000387,49568,960Mar 05 08:30 PM
FLATLEY JAY TChief Executive OfficerFeb 26Option Exercise33.8025,000844,875452,850Feb 27 06:53 PM
FLATLEY JAY TChief Executive OfficerFeb 26Sale195.7325,0004,893,227427,850Feb 27 06:53 PM
WALT DAVID RDirectorFeb 24Sale199.519,5031,895,975832,427Feb 26 07:57 PM
Bianchi Paul LSr VP Human ResourcesFeb 19Sale199.9916,9513,390,01274,667Feb 23 07:54 PM
WALT DAVID RDirectorFeb 17Sale197.985,000989,925841,930Feb 19 07:10 PM
WALT DAVID RDirectorFeb 17Sale198.102,000396,20070,960Feb 19 07:10 PM
FLATLEY JAY TChief Executive OfficerFeb 12Option Exercise22.7925,000569,775377,241Feb 13 07:38 PM
FLATLEY JAY TChief Executive OfficerFeb 12Sale194.6425,0004,865,990357,241Feb 13 07:38 PM
WALT DAVID RDirectorFeb 10Sale193.625,000968,090846,930Feb 12 07:45 PM
WALT DAVID RDirectorFeb 03Sale190.885,000954,381851,930Feb 05 08:14 PM
WALT DAVID RDirectorFeb 03Sale190.922,000381,83772,960Feb 05 08:14 PM
EASTHAM KARINDirectorFeb 02Option Exercise43.9210,000439,18516,226Feb 03 08:37 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Option Exercise69.3463243,82325,452Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Option Exercise69.3411,250780,07534,268Feb 02 09:28 PM
EASTHAM KARINDirectorFeb 02Sale192.7710,0001,927,7089,726Feb 03 08:37 PM
Bianchi Paul LSr VP, Human ResourcesFeb 02Sale195.371,035202,20857,715Feb 02 09:26 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Sale195.37632123,47424,820Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Sale193.0211,2502,171,45823,018Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Option Exercise43.374,000173,48028,129Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Sale198.174,000792,69124,129Feb 02 09:28 PM
WALT DAVID RDirectorJan 27Option Exercise6.234,00024,900860,930Jan 29 06:34 PM
WALT DAVID RDirectorJan 27Sale201.764,000807,047856,930Jan 29 06:34 PM
Dadswell CharlesSr VP & General CounselJan 27Sale198.9022444,55443,036Jan 28 07:00 PM
FLATLEY JAY TChief Executive OfficerJan 22Option Exercise20.0425,000501,000390,478Jan 23 08:06 PM
FLATLEY JAY TChief Executive OfficerJan 22Sale188.4825,0004,712,079365,478Jan 23 08:06 PM
WALT DAVID RDirectorJan 20Option Exercise6.234,00024,900860,930Jan 22 05:54 PM
RASTETTER WILLIAM HDirectorJan 20Option Exercise6.2316,00099,60021,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 20Sale194.432,000388,85474,960Jan 22 05:54 PM